Temozolomide (Temodar)
Temozolomide (pronounced [te moe ZOE loe mide]) is also known by the brand name Temodar. Temozolomide is an antineoplastic (anti-cancer) drug that belongs to a class called alkylating agents. It is a type of chemotherapy that prevents cancer cells from
Sorafenib (Nexavar)
Sorafenib (pronounced [sor AF e nib]) is also known by the brand name, Nexavar. Sorafenib is currently only available as the brand Nexavar, and there is no generic available. It is an antineoplastic (anti-cancer) drug that belongs to a class
Bevacizumab (Avastin)
Bevacizumab (pronounced [be vuh SIZ uh mab]) is also known by the brand name, Avastin. Bevacizumab is currently only available as the brand Avastin, and there is no generic available. It also has two approved biosimilars called Zirabev and Mvasi.
Erlotinib (Tarceva)
Erlotinib, also known as Tarceva, is a targeted cancer drug used to treat metastatic non-small cell lung cancer (NSCLC) in patients with a specific gene mutation (EGFR exon 19 deletion or exon 21 [L858R] substitution mutations) as first-line therapy, maintenance
Enzalutamide (Xtandi)
Enzalutamide (pronounced [en za LOO ta mide]) is also known by the brand name, Xtandi. It is currently only available as the brand, Xtandi, and there is no generic available. Xtandi is an antineoplastic (anti-cancer) drug that belongs to a
Fulvestrant (Faslodex)
Fulvestrant (pronounced [fool VES trant]) is also known by the brand name, Faslodex. It is an antineoplastic (anti-cancer) drug that belongs to a class called estrogen receptor antagonists. It is an injectable solution that is used to treat locally advanced